Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alphanate in Preventing Excessive Bleeding During Surgery in Type 3 Von Willebrand Disease
NCT00555555Phase 4Terminated
- Sponsor
- Grifols
- Start
- Jul 2008
- Primary completion
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of coagulation factor IX human in von Willebrand disease (VWD), sponsored by Grifols. Started Jul 2008; status: terminated.
02
Drugs
coagulation factor IX human
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT00555555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555555.